| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,394 |
36,590 |
$6.81M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,647 |
12,877 |
$2.34M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,557 |
6,498 |
$1.17M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
767 |
737 |
$128K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
652 |
620 |
$111K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,292 |
2,647 |
$80K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
163 |
159 |
$27K |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
33 |
31 |
$17K |
| 0502F |
|
835 |
642 |
$14K |
| 36416 |
|
12,273 |
10,555 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
40 |
40 |
$7K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
972 |
819 |
$6K |
| 90686 |
|
1,063 |
978 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,199 |
5,652 |
$4K |
| 90688 |
|
665 |
579 |
$4K |
| 99442 |
|
18 |
15 |
$4K |
| 3008F |
|
28,312 |
24,641 |
$4K |
| 82962 |
|
3,031 |
2,559 |
$3K |
| 1000F |
|
1,392 |
1,144 |
$3K |
| 3725F |
|
13,269 |
11,164 |
$3K |
| 81025 |
|
613 |
546 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$2K |
| 81003 |
|
10,438 |
7,891 |
$2K |
| 0002A |
|
88 |
86 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
17,465 |
15,091 |
$1K |
| 0001A |
|
64 |
62 |
$1K |
| 90715 |
|
95 |
80 |
$1K |
| 97810 |
|
39 |
25 |
$976.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,089 |
2,859 |
$937.29 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
924 |
904 |
$778.17 |
| 0011A |
|
17 |
16 |
$260.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,287 |
1,162 |
$253.50 |
| 3074F |
|
5,172 |
4,518 |
$195.20 |
| 92551 |
|
345 |
336 |
$187.45 |
| 87430 |
|
472 |
461 |
$177.44 |
| 85018 |
|
795 |
676 |
$83.05 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
86 |
84 |
$72.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
388 |
377 |
$71.39 |
| 87400 |
|
109 |
106 |
$63.58 |
| 3044F |
|
236 |
223 |
$0.00 |
| 3079F |
|
955 |
890 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
102 |
101 |
$0.00 |
| 3075F |
|
142 |
137 |
$0.00 |
| 87428 |
|
59 |
55 |
$0.00 |
| 90732 |
|
21 |
17 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
24 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
39 |
39 |
$0.00 |
| 3078F |
|
4,800 |
4,177 |
$0.00 |
| 90473 |
|
176 |
173 |
$0.00 |
| 80305 |
|
995 |
880 |
$0.00 |
| 99173 |
|
221 |
219 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
598 |
517 |
$0.00 |
| 87210 |
|
58 |
55 |
$0.00 |